Capital International Investors 13D and 13G filings for NovoCure Limited:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 6:03 pm Purchase |
2024-02-07 | 13G | NovoCure Limited NVCR |
Capital International Investors | 8,896,076 8.300% |
740,167 (+9.08%) |
Filing |
| 2023-02-13 3:54 pm Sale |
2023-02-14 | 13G | NovoCure Limited NVCR |
Capital International Investors | 8,155,909 7.800% |
-3,375,166 (-29.27%) |
Filing |
| 2022-02-11 11:19 am Purchase |
2022-02-14 | 13G | NovoCure Limited NVCR |
Capital International Investors | 11,531,075 11.100% |
822,013 (+7.68%) |
Filing |
| 2021-08-10 12:28 pm Purchase |
2021-08-10 | 13G | NovoCure Limited NVCR |
Capital International Investors | 10,709,062 10.300% |
2,271,587 (+26.92%) |
Filing |
| 2021-02-16 1:57 pm Purchase |
2021-02-16 | 13G | NovoCure Limited NVCR |
Capital International Investors | 8,437,475 8.300% |
8,437,475 (New Position) |
Filing |